Beneficial effect of an antibody against interleukin-2 receptor (daclizumab) in an experimental model of hepatocyte xenotransplantation

doi:10.3748/wjg.v13.i9.1435

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 9

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2241)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

332

HTML

1425

Figures (1-1)

257

Tables (1-3)

227

Sum=2241

Mar 7, 2007 (publication date) through Nov 9, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Mar 7, 2007; 13(9): 1435-1437
Published online Mar 7, 2007. doi: 10.3748/wjg.v13.i9.1435

Beneficial effect of an antibody against interleukin-2 receptor (daclizumab) in an experimental model of hepatocyte xenotransplantation

Dimitrios Papagoras, Apostolos Papalois, Alexandra Tsaroucha, Dimitrios Lytras, John Kyriazanos, Nikoletta Giannakou, Prodromos Laftsidis, Constantine Simopoulos

Dimitrios Papagoras, Apostolos Papalois, Alexandra Tsaroucha, Dimitrios Lytras, John Kyriazanos, Prodromos Laftsidis, Constantine Simopoulos, 2^nd Department of Surgery, Medical School, “Democritus” University of Thrace, Alexandroupolis, Greece

Apostolos Papalois, Experimental-Research Department, Elpen Pharmaceuticals, Athens, Greece

Nikoletta Giannakou, Department of Pathology, “Aghia Olga” General Hospital, Athens, Greece

Author contributions: All authors contributed equally to the work.

Correspondence to: Apostolos Papalois, PhD, Experimental-Research Department, Elpen Pharmaceuticals, 60 El. Venizelou st., 153 41 Aghia Paraskevi, Athens, Greece. apo@hol.gr

Telephone: +30-210-6537045 Fax: +30-210-6537045

Received: November 30, 2006
Revised: December 25, 2006
Accepted: January 18, 2007
Published online: March 7, 2007

Core Tip